These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 8529133)

  • 1. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.
    Poli G; Kinter AL; Fauci AS
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):108-12. PubMed ID: 7506410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin (IL)-4 inhibits phorbol-ester induced HIV-1 expression in chronically infected U1 cells independently from the autocrine effect of endogenous tumour necrosis factor-alpha, IL-1beta, and IL-1 receptor antagonist.
    Goletti D; Kinter AL; Coccia EM; Battistini A; Petrosillo N; Ippolito G; Poli G
    Cytokine; 2002 Jan; 17(1):28-35. PubMed ID: 11886168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal superantigens activate HIV-1 replication in naturally infected monocytes.
    Goujard C; Wallon C; Rudent A; Boué F; Barre-Sinoussi F; Delfraissy JF
    AIDS; 1994 Oct; 8(10):1397-404. PubMed ID: 7818810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
    Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
    AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-kappa B activity and production of tumor necrosis factor-alpha.
    Gollapudi S; Kim CH; Patel A; Sindhu R; Gupta S
    Biochem Biophys Res Commun; 1996 Sep; 226(3):889-94. PubMed ID: 8831706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells.
    Goletti D; Kinter AL; Hardy EC; Poli G; Fauci AS
    J Immunol; 1996 May; 156(9):3501-8. PubMed ID: 8617979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
    Rabbi MF; Finnegan A; Al-Harthi L; Song S; Roebuck KA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):321-31. PubMed ID: 9833740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
    Okamoto M; Ono M; Baba M
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1239-45. PubMed ID: 9764907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
    Kinter AL; Biswas P; Alfano M; Justement JS; Mantelli B; Rizzi C; Gatti AR; Vicenzi E; Bressler P; Poli G
    Mol Med; 2001 Oct; 7(10):668-78. PubMed ID: 11713366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
    J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
    Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
    Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-8 fails to induce human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells but differentially modulates induction by proinflammatory cytokines.
    Tiemessen CT; Kilroe B; Martin DJ
    Immunology; 2000 Sep; 101(1):140-6. PubMed ID: 11012765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of HIV replication in mononuclear phagocytes by leukemia inhibitory factor.
    Broor S; Kusari AB; Zhang B; Seth P; Richman DD; Carson DA; Wachsman W; Lotz M
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):647-54. PubMed ID: 8207643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 18 stimulates HIV type 1 in monocytic cells.
    Shapiro L; Puren AJ; Barton HA; Novick D; Peskind RL; Shenkar R; Gu Y; Su MS; Dinarello CA
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12550-5. PubMed ID: 9770523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
    Angel JB; Saget BM; Walsh SP; Greten TF; Dinarello CA; Skolnik PR; Endres S
    AIDS; 1995 Oct; 9(10):1137-44. PubMed ID: 8519449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells.
    Han X; Becker K; Degen HJ; Jablonowski H; Strohmeyer G
    Eur J Clin Invest; 1996 Apr; 26(4):286-92. PubMed ID: 8732485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.
    Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA
    Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.